TILRAY BRANDS Reports Fourth Quarter Earnings Results for FY2023
July 28, 2023
🌥️Earnings Overview
TILRAY BRANDS ($NASDAQ:TLRY) released their financial results for the fourth quarter of FY2023, which ended on May 31, 2023, on July 26, 2023. Revenue amounted to USD 184.2 million, a 20.1% increase year-over-year. Net income was reported to be USD -119.8 million, a much better performance than the -457.8 million reported in the same quarter of the previous year.
Share Price
The stock opened at $2.0 and closed at $1.9, soaring by 14.9% from its previous closing price of $1.7. This was a stellar performance for the company, which has been steadily growing in the past year. The company also reported an increase in revenue from its core products, such as cannabis-derived pharmaceuticals, beverages, and edibles. The strong performance of TILRAY BRANDS’ products is expected to continue into the next quarter as the company expands into new markets and continues to innovate.
The company also plans to increase its marketing efforts to reach a wider audience and build on their brand recognition. TILRAY BRANDS is confident that its strategies will continue to help the company reach success in the future. With its promising outlook, investors can look forward to further growth and positive returns for the company in the months ahead. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Tilray Brands. More…
| Total Revenues | Net Income | Net Margin |
| 627.12 | -1.45k | -79.2% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Tilray Brands. More…
| Operations | Investing | Financing |
| 7.91 | -285.11 | 70.16 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Tilray Brands. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 4.31k | 977.32 | 5.05 |
Key Ratios Snapshot
Some of the financial key ratios for Tilray Brands are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 17.1% | 7.2% | -223.8% |
| FCF Margin | ROE | ROA |
| -2.1% | -26.1% | -20.4% |
Analysis
At GoodWhale, we have conducted a thorough analysis of the fundamentals of Tilray Brands. Our assessment of the company’s financial and business risk has revealed that Tilray Brands is a high-risk investment. In addition to this, GoodWhale has detected three risk warnings in Tilray Brands’ income sheet, balance sheet, and cashflow statement. If you want to learn more about what these risk warnings are and what they mean for your investment decision, be sure to register with us to check it out. More…
Peers
Its competitors are IM Cannabis Corp, Cansortium Inc, and Aurora Cannabis Inc.
– IM Cannabis Corp ($NASDAQ:IMCC)
Organigram Holdings Inc. is a Canada-based company, which offers various cannabis products. The company’s portfolio of brands include ANKR Organics, Edison Cannabis Co., Trailer Park Buds, and The Edison Cannabis Company. It operates through its subsidiary, Organigram Inc. The company offers dried cannabis, cannabis oils, capsules, and pre-rolls. It also provides adult-use recreational cannabis in Canada.
– Cansortium Inc ($OTCPK:CNTMF)
Consortium Inc is a publicly traded company with a market capitalization of $41.63 million as of 2022. The company has a return on equity of 25.1%, meaning that it has generated a profit for shareholders of $25.1 million over the past year. Consortium Inc is a leading provider of engineering and construction services, with a focus on the energy, industrial, and infrastructure markets. The company has a strong track record of delivering quality projects on time and on budget, and has a reputation for being a dependable partner for its clients.
– Aurora Cannabis Inc ($TSX:ACB)
Aurora Cannabis Inc is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and the New York Stock Exchange under the ticker ACB. The company produces and sells medical cannabis products in Canada, the European Union, the United Kingdom, and Australia. Aurora also has operations in Brazil.
Summary
Tilray Brands reported their fourth quarter earnings for FY2023 on July 26th, with total revenue up 20.1% from the previous year. Net income was -119.8 million, a substantial improvement from -457.8 million in the same period last year. This news excited investors, as the stock price rose on the same day.
As a result, Tilray Brands is a promising investment opportunity, given the increasing revenue and decreasing net losses. Investors should watch for further developments in the company, such as expansions in their product line and increased market saturation, in order to gain a better picture of the future potential for Tilray Brands.
Related Posts
Recent Posts
